Hypothyroidism in coronary heart disease and its relation to selected risk factors

Vascular Health and Risk Management

Volumn 2, Issue 4, 2006, Pages 499-506

  Mayer Jr , Otto ^a   Šimon, Jaroslav ^a   Filipovský, Jan ^a   Pláškova, Markéta ^b   Pikner, Richard ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Cholesterol; Coronary heart disease; Diabetes; Homocysteine; Hypothyroidism

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; LEVOTHYROXINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; EUTHYROIDISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; THYROID DISEASE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; CZECH REPUBLIC; FEMALE; HOMOCYSTEINE; HUMANS; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SEX FACTORS; THYROTROPIN; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 33846913746     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: 10.2147/vhrm.2006.2.4.499     Document Type: Article

References (28)

1. Baloch Z, Carayon P, Conte-Devolx B, et al. 2003. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 13: 3-126.
2. Becker C. 1985. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev, 6:432-40.
3. Canaris GJ, Manowitz NR, Mayor G, et al. 2000. The Colorado thyroid disease prevalence study. Arch Intern Med, 160:526-34.
4. Caraccio N, Ferrannini E, Monzani F. 2002. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab, 87:1533-8.
5. Cimino JA, Jhangiani S, Schwarz E, et al.1987. Riboflavin metabolism in the hypothyroid human adult. Proc Sec Exp Biol Med, 184:151-3.
6. Christ-Crain M, Meier C, Guglielmetti M, et al. 2003. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis, 166:379-86.
7. Danese MD, Ladenson PW, Meinert CL, et al. 2000. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature. J Clin Endocrinol Metab, 85:2993-3000.
8. Duckworth WC, Badlissi J, Kitabchi AE. 1986. Thyroid function in diabetes. In Vanmiddleworth L, ed. The thyroid gland. Chicago: Year Book Medical. p. 247-61.
9. Hak AE, Pols HAP, Visser TJ et al. 2000. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women. The Rotterdam study. Ann Intern Med, 132:270-8.
10. EUROASPIRE II Group. 2001. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Eur Heart J, 22:554-72.
11. Flynn RW, MacDonald TM, Jung RT, et al. 2006. Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab, 91:2159-64.
12. Gartner W, Weissel M. 2004. Do iodine-containing contrast media induce clinically relevant changes in thyroid function parameters of euthyroid patients within the first week? Thyroid, 14:521-4.
13. Gray RS, Irvine WJ, Clarke BF. 1979. Screening for thyroid dysfunction in diabetics. Br Med J, 2:1439.
14. Hollowell J, Staehling NW, Flanders WD, et al. 2002. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 87:489-99.
15. Kreisman SH, Hennessey JV. 1999. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med, 159:79-82.
16. Mayer O Jr, Simon J, Hrbkova J, et al. 2005. Epidemiological study of hypothyroidism as cardiovascular risk in population. Cas Lek Cesk, 144:459-64.
17. Meier C, Staub JJ, Roth CB, et al. 2001. TSH-controlled L-thyroxine therapy reduces cholesterol levels, clinical symptoms in subclinical hypothyroidsm? A double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab, 86:4860-4.
18. Perros P, McCrimmon RJ, Shaw G, et al. 1995. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med, 12:622-7.
19. Rivlin RS, Landon RG. 1966. Regulation of hepatic FAD levels by thyroid hormone. Adv Enzyme Regul, 4:45-58.
20. Roehon C, Tauveron I, Dejax C. 2003. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci, 104:7-15.
21. Samuel MH. 1998. Subclinical thyroid disease in the elderly. Thyroid, 8:803-13.
22. Scarbottolo L, Trezze E, Roma P et al. 1986. Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis, 59:329-33.
23. Shane B, Stokstad EL. 1985. Vitamin B12-folate interrelationships. Ann Rev Nutr, 5:115-41.
24. Taddei S, Caraccio N, Virdis A et al. 2004. Impaired endothelium-dependent vasadilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab, 88:3731-7.
25. Thomson GR, Souter AK, Spengel FA et al. 1981. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sc USA, 78:2591-5.
26. Umpierrez GE, Kashif AL, Murphy MB. 2003. Thyroid dysfunction in patients with Type 1 Diabetes A longitudinal study. Diabetes Care, 26:1181-5.
27. Vanderpump MPJ, Tunbridge WMG. 1996. The epidemiology of thyroid disease. In Braveman LE, Utiger RD, eds. The Thyroid 9th ed. Piladelphia: Lippincott-Raven Publisher, p. 474-82
28. Wald DS, Law M, Morris JK. 2002. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J, 325:1202-6.